A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Open accessAbstract
The immune system is critical in modulating cancer progression, but knowledge of immune composition, phenotype, and interactions with tumor is limited. We used multiplexed ion beam imaging by time-of-flight (MIBI-TOF) to simultaneously quantify in situ expression of 36 proteins covering identity, function, and immune regulation at sub-cellular resolution in 41 triple-negative breast cancer patients. Multi-step processing, including deep-learning-based segmentation, revealed variability in the composition of tumor-immune populations across individuals, reconciled by overall immune infiltration and enriched co-occurrence of immune subpopulations and checkpoint expression. Spatial enrichment analysis showed immune mixed and compartmentalized tumors, coinciding with expression of PD1, PD-L1, and IDO in a cell-type- and location-specific manner. Ordered immune structures along the tumor-immune border were associated with compartmentalization and linked to survival. These data demonstrate organization in the tumor-immune microenvironment that is structured in cellular composition, spatial arrangement, and regulatory-protein expression and provide a framework to apply multiplexed imaging to immune oncology.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nuclear segmentation was performed with DeepCell using in-house training and validation MIBI imaging datasets from a variety of human clinical tissue types to ensure reproducibility.
“Nuclear segmentation was performed with DeepCell (Van Valen et al., 2016) (https://github.com/vanvalenlab/deepcell-tf) as previously described (Keren et al., 2018), using in-house training and validation MIBI imaging datasets from a variety of human clinical tissue types to ensure reproducibility.”
From Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma (2020) · cites this paper as Keren et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · see citing works
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,314 · see citing works
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883 · cited 1× · see citing works
“Since H3K9ac was shown to be correlated with open chromatin and H3K27me3 with closed chromatin (Kouzarides, 2007), these global changes in their ratios may indicate that cells on the tumor border are more transcriptionally active than those in the tumor center.”
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157 · see citing works
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791 · see citing works
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · see citing works
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609 · see citing works
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · see citing works
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231 · see citing works
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237 · see citing works
Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., den Eynden, G. V., Baehner, F. L., Penault-Llorca, F. M., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu450 · Cited by 3,142 · see citing works
Spatially resolved, highly multiplexed RNA profiling in single cells
Chen, K. H., Boettiger, A. N., Moffitt, J. R., Wang, S., & Zhuang, X. (2015) · Science · doi:10.1126/science.aaa6090 · Cited by 2,969 · see citing works
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
Postow, M. A., Chesney, J., Pavlick, A. C., Robert, C., Grossmann, K., McDermott, D., Linette, G. P., Meyer, N., Giguere, J. K., Agarwala, S. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414428 · Cited by 2,781 · see citing works
PD-L1 expression as a predictive biomarker in cancer immunotherapy
Patel, S. P., & Kurzrock, R. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0983 · Cited by 2,291 · see citing works
Bendall, S. C., Simonds, E. F., Qiu, P., Amir, E.-A. D., Krutzik, P. O., Finck, R., Bruggner, R. V., Melamed, R., Trejo, A., Ornatsky, O. I., et al. (2011) · Science · doi:10.1126/science.1198704 · Cited by 2,279 · see citing works
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
Giesen, C., Wang, H. A. O., Schapiro, D., Zivanovic, N., Jacobs, A., Hattendorf, B., Schüffler, P. J., Grolimund, D., Buhmann, J. M., Brandt, S., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2869 · Cited by 1,951 · see citing works
FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data
Gassen, S. V., Callebaut, B., van Helden, M. J. G., Lambrecht, B. N., Demeester, P. M. A., Dhaene, T., & Saeys, Y. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22625 · Cited by 1,930 · see citing works
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb‐Esfahani, S., Kronenwett, R., Hanusch, C. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,761 · see citing works
Seiwert, T. Y., Burtness, B., Mehra, R., Weiss, J., Berger, R., Eder, J. P., Heath, K., McClanahan, T., Lunceford, J., Gause, C., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30066-3 · Cited by 1,745 · cited 1× · see citing works
“Although preliminary, overall response rates typically range 15–30%, similar to observations in gastric and head and neck cancers (Muro et al., 2016; Seiwert et al., 2016).”
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,739 · see citing works
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647 · see citing works
Topographic distance and watershed lines
Meyer, F. (1994) · Signal Processing · doi:10.1016/0165-1684(94)90060-4 · Cited by 1,447 · see citing works
Lehmann, B. D., Jovanović, B., Chen, X., Estrada, M. V., Johnson, K. N., Shyr, Y., Moses, H. L., Sanders, M. E., & Pietenpol, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157368 · Cited by 1,440 · see citing works
Classifying Cancers Based on T-cell Infiltration and PD-L1
Teng, M. W. L., Ngiow, S. F., Ribas, A., & Smyth, M. J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0255 · Cited by 1,412 · see citing works
Burstein, M. D., Tsimelzon, A. I., Poage, G. M., Covington, K. R., Contreras, A., Fuqua, S. A. W., Savage, M. I., Osborne, C. K., Hilsenbeck, S. G., Chang, J. C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0432 · Cited by 1,404 · see citing works
Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy
Gao, J., Shi, L. Z., Zhao, H., Chen, J., Xiong, L., He, Q., Chen, T., Roszik, J., Bernatchez, C., Woodman, S. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.069 · Cited by 1,300 · see citing works
Muro, K., Chung, H. C., Shankaran, V., Geva, R., Catenacci, D. V. T., Gupta, S., Eder, J. P., Golan, T., Le, D. T., Burtness, B. A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00175-3 · Cited by 1,117 · see citing works
Multiplexed ion beam imaging of human breast tumors
Angelo, M., Bendall, S. C., Finck, R., Hale, M. B., Hitzman, C., Borowsky, A. D., Levenson, R. M., Lowe, J. B., Liu, S. D., Zhao, S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3488 · Cited by 1,108 · see citing works
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Chevrier, S., Levine, J., Zanotelli, V. R., Siliņa, K., Schulz, D., Bacac, M., Ries, C. H., Ailles, L., Jewett, M. A. S., Moch, H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.016 · Cited by 1,009 · see citing works
Highly Multiplexed Subcellular RNA Sequencing in Situ
Lee, J. H., Daugharthy, E. R., Scheiman, J., Kalhor, R., Yang, J. L., Ferrante, T. C., Terry, R., Jeanty, S. S. F., Li, C., Amamoto, R., et al. (2014) · Science · doi:10.1126/science.1250212 · Cited by 973 · see citing works
LAG3 (CD223) as a Cancer Immunotherapy Target
Andrews, L. P., Marciscano, A., Drake, C., & Vignali, D. A. A. (2017) · Immunological Reviews · doi:10.1111/imr.12519 · Cited by 881 · see citing works
Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
Denkert, C., Liedtke, C., Tutt, A. N. J., & von Minckwitz, G. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32454-0 · Cited by 875 · see citing works
Van Valen, D. A., Kudo, T., Lane, K. M., Macklin, D. N., Quach, N. T., DeFelice, M. M., Maayan, I., Tanouchi, Y., Ashley, E. A., & Covert, M. W. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005177 · Cited by 557 · see citing works
Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice
Matos, L. L., Trufelli, D. C., de Matos, M. G. L., & Pinhal, M. A. D. S. (2010) · Biomarker Insights · doi:10.4137/bmi.s2185 · Cited by 442 · see citing works
Combination immunotherapy: a road map
Ott, P. A., Hodi, F. S., Kaufman, H. L., Wigginton, J. M., & Wolchok, J. D. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0218-5 · Cited by 379 · see citing works
Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection
Dunn, C., Peppa, D., Khanna, P., Nebbia, G., Jones, M., Brendish, N. J., Lascar, R. M., Brown, D. J., Gilson, R. J. C., Tedder, R. S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.054 · Cited by 362 · see citing works
Biomarkers of response to PD-1/PD-L1 inhibition
Vareki, S. M., Garrigós, C., & Durán, I. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.06.001 · Cited by 319 · see citing works
Nirschl, C. J., & Drake, C. G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1972 · Cited by 308 · see citing works
Checkpoint inhibitors in triple‐negative breast cancer (TNBC): Where to go from here
Kwa, M. J., & Adams, S. (2018) · Cancer · doi:10.1002/cncr.31272 · Cited by 213 · see citing works
André, F., Dieci, M. V., Dubsky, P. C., Sotiriou, C. P., Curigliano, G., Denkert, C., & Loi, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2701 · Cited by 195 · see citing works
Burugu, S., Gao, D., Leung, S. C. Y., Chia, S., & Nielsen, T. O. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx557 · Cited by 188 · see citing works
Minin, G. D., Bellazzo, A., Ferro, M. D., Chiaruttini, G., Nuzzo, S., Bicciato, S., Piazza, S., Rami, D., Bulla, R., Sommaggio, R., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.013 · Cited by 165 · see citing works
Enhancement of T cell recruitment and infiltration into tumours
Oelkrug, C., & Ramage, J. M. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12382 · Cited by 140 · see citing works
Huang, W., Hennrick, K. T., & Drew, S. A. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.05.009 · Cited by 136 · see citing works
Yeong, J. P.-S., Thike, A. A., Lim, J. C. T., Lee, B. T. K., Li, H., Wong, S. C., Hue, S. S., Tan, P. H., & Iqbal, J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4161-4 · Cited by 133 · see citing works
Carrel, S., Schmidt-Kessen, A., & Giuffrè, L. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150204 · Cited by 116 · see citing works
New Immunotherapy Strategies in Breast Cancer
Yu, L., Tang, J., Zhang, C., Zeng, W., Yan, H., Li, M.-P., & Chen, X. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14010068 · Cited by 115 · see citing works
Triple-Negative Breast Cancer: Immune Modulation as the New Treatment Paradigm
Disis, M. L., & Stanton, S. E. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e25 · Cited by 108 · see citing works
Fortis, S. P., Sofopoulos, M., Sotiriadou, N. N., Haritos, C., Vaxevanis, C., Anastasopoulou, E. A., Janssen, N., Arnogiannaki, N., Ardavanis, A. S., Pawelec, G., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0240-7 · Cited by 89 · see citing works
Indoleamine 2,3-dioxygenase, Tregs and Cancer
Munn, D. H. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795656045 · Cited by 81 · see citing works
Dense transcript profiling in single cells by image correlation decoding
Coskun, A. F., & Cai, L. (2016) · Nature Methods · doi:10.1038/nmeth.3895 · Cited by 74 · see citing works
The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?
Troncone, G., & Gridelli, C. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.10.05 · Cited by 32 · see citing works
Cellular dynamics of resolving inflammation
Bagaitkar, J. (2014) · Blood · doi:10.1182/blood-2014-07-589341 · Cited by 12 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Haralick RM, Shanmugam K, and Dinstein I (1973). Textural Features for Image Classification. IEEE Trans. Syst. Man. Cybern SMC-3, 610– 621.
- Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. PLoS One 11, e0157368. PMC4911051 27310713
Cited by
Sorted by citations
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453 · see citing works
Zhang, Y., & Zhang, Z. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,815 · see citing works
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296 · see citing works
Tumor microenvironment as a therapeutic target in cancer
Xiao, Y. Q., & Yu, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107753 · Cited by 1,977 · see citing works
Exploring tissue architecture using spatial transcriptomics
Rao, A., Barkley, D., França, G. S., & Yanai, I. (2021) · Nature · doi:10.1038/s41586-021-03634-9 · Cited by 1,700 · see citing works
Microglia Biology: One Century of Evolving Concepts
Prinz, M., Jung, S., & Priller, J. (2019) · Cell · doi:10.1016/j.cell.2019.08.053 · Cited by 1,525 · see citing works
Garrido-Castro, A. C., Lin, N. U., & Polyak, K. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1177 · Cited by 1,451 · see citing works
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
Bianchini, G., Angelis, C. D., Licata, L., & Gianni, L. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00565-2 · Cited by 1,425 · see citing works
Deep learning for cellular image analysis
Moen, E., Bannon, D., Kudo, T., Graf, W., Covert, M., & Van Valen, D. (2019) · Nature Methods · doi:10.1038/s41592-019-0403-1 · Cited by 1,225 · see citing works
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Ji, A. L., Rubin, A. J., Thrane, K., Jiang, S., Reynolds, D. L., Meyers, R. M., Guo, M. G., George, B. M., Mollbrink, A., Bergenstråhle, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.039 · Cited by 1,117 · see citing works
“Recent advances, however, enable simultaneous capture of the locations of dozens of cell types within the TME, which is critical for understanding tumor-stroma crosstalk (Angelo et al., 2014; Keren et al., 2018; Salmén et al., 2018a; Thrane et al., 2018).”
BackgroundTertiary lymphoid structures in cancer
Schumacher, T. N., & Thommen, D. S. (2022) · Science · doi:10.1126/science.abf9419 · Cited by 1,147 · see citing works
Multiplex digital spatial profiling of proteins and RNA in fixed tissue
Merritt, C. R., Ong, G. T., Church, S. E., Barker, K., Danaher, P., Geiss, G., Hoang, M., Jung, J., Liang, Y., McKay-Fleisch, J., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0472-9 · Cited by 1,072 · see citing works
Schürch, C. M., Bhate, S. S., Barlow, G. L., Phillips, D. J., Noti, L., Zlobec, I., Chu, P., Black, S., Demeter, J., McIlwain, D. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.005 · Cited by 1,058 · see citing works
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,042 · see citing works
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Marusyk, A., Janiszewska, M., & Polyak, K. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.007 · Cited by 1,009 · see citing works
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdiş, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 982 · see citing works
Greenwald, N. F., Miller, G., Moen, E., Kong, A., Kagel, A., Dougherty, T., Fullaway, C. C., McIntosh, B. J., Leow, K. X., Schwartz, M. S., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01094-0 · Cited by 953 · see citing works
Giotto: a toolbox for integrative analysis and visualization of spatial expression data
Dries, R., Zhu, Q., Dong, R., Eng, C.-H. L., Li, H., Liu, K., Fu, Y., Zhao, T., Sarkar, A., Bao, F., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02286-2 · Cited by 921 · see citing works
The single-cell pathology landscape of breast cancer
Jackson, H. W., Fischer, J. R., Zanotelli, V. R., Ali, H. R., Mechera, R., Soysal, S. D., Moch, H., Muenst, S. E., Varga, Z., Weber, W. P., et al. (2020) · Nature · doi:10.1038/s41586-019-1876-x · Cited by 891 · see citing works
Triple negative breast cancer: Pitfalls and progress
Zagami, P., & Carey, L. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00468-0 · Cited by 899 · see citing works
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
Wagner, J., Rapsomaniki, M., Chevrier, S., Anzeneder, T., Langwieder, C., Dykgers, A., Rees, M., Ramaswamy, A., Muenst, S. E., Soysal, S. D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.005 · Cited by 784 · see citing works
Deciphering breast cancer: from biology to the clinic
Nolan, E., Lindeman, G. J., & Visvader, J. E. (2023) · Cell · doi:10.1016/j.cell.2023.01.040 · Cited by 761 · see citing works
CODEX multiplexed tissue imaging with DNA-conjugated antibodies
Black, S. A., Phillips, D. J., Hickey, J. W., Kennedy‐Darling, J., Venkataraaman, V. G., Samusik, N., Goltsev, Y., Schürch, C. M., & Nolan, G. P. (2021) · Nature Protocols · doi:10.1038/s41596-021-00556-8 · Cited by 668 · see citing works
Improving cancer immunotherapy through nanotechnology
Goldberg, M. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0186-9 · Cited by 628 · see citing works
Spatial omics and multiplexed imaging to explore cancer biology
Lewis, S. M., Asselin-Labat, M.-L., Nguyen, Q. H., Berthelet, J., Tan, X., Wimmer, V. C., Mérino, D., Rogers, K. L., & Naik, S. H. (2021) · Nature Methods · doi:10.1038/s41592-021-01203-6 · Cited by 609 · see citing works
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade
Lu, S., Stein, J. E., Rimm, D. L., Wang, D. W., Bell, M. A., Johnson, D. B., Sosman, J. A., Schalper, K. A., Anders, R. A., Wang, H., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1549 · Cited by 618 · see citing works
Bressan, D., Battistoni, G., & Hannon, G. J. (2023) · Science · doi:10.1126/science.abq4964 · Cited by 606 · see citing works
Spatial profiling technologies illuminate the tumor microenvironment
Elhanani, O., Ben-Uri, R., & Keren, L. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.010 · Cited by 526 · see citing works
Fu, T., Dai, L.-J., Wu, S.-Y., Xiao, Y., Ma, D., Jiang, Y.-Z., & Shao, Z.-M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01103-4 · Cited by 480 · see citing works
Resistance Mechanisms to Anti-PD Cancer Immunotherapy
Vesely, M. D., Zhang, T., & Chen, L. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-070621-030155 · Cited by 468 · see citing works
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
Gruosso, T., Gigoux, M., Manem, V. S., Bertos, N., Zuo, D., Perlitch, I., Saleh, S. M. I., Zhao, H., Souleimanova, M., Johnson, R. M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci96313 · Cited by 445 · see citing works
The emerging landscape of spatial profiling technologies
Moffitt, J. R., Lundberg, E., & Heyn, H. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00515-3 · Cited by 419 · see citing works
Chan, J. M., Quintanal-Villalonga, À., Gao, V. R., Xie, Y., Allaj, V., Chaudhary, O., Masilionis, I., Egger, J. V., Chow, A. T., Walle, T., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.09.008 · Cited by 440 · see citing works
MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure
Keren, L., Bosse, M. M., Thompson, S., Risom, T., Vijayaragavan, K., McCaffrey, E., Marquez, D. M., Angoshtari, R., Greenwald, N. F., Fienberg, H. G., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax5851 · Cited by 441 · see citing works
Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
Vuong, L. H., Kotecha, R. R., Voss, M. H., & Hakimi, A. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0499 · Cited by 437 · see citing works
Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems
Alon, S., Goodwin, D., Sinha, A., Wassie, A. T., Chen, F., Daugharthy, E. R., Bando, Y., Kajita, A., Xue, A. G., Marrett, K., et al. (2021) · Science · doi:10.1126/science.aax2656 · Cited by 413 · see citing works
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433 · see citing works
Single-cell spatial immune landscapes of primary and metastatic brain tumours
Karimi, E., Yu, M. W., Maritan, S. M., Perus, L. J. M., Rezanejad, M., Sorin, M., Dankner, M., Fallah, P., Doré, S., Zuo, D., et al. (2023) · Nature · doi:10.1038/s41586-022-05680-3 · Cited by 401 · see citing works
Risom, T., Glass, D. R., Averbukh, I., Liu, C. C., Baranski, A., Kagel, A., McCaffrey, E., Greenwald, N. F., Rivero‐Gutiérrez, B., Strand, S. H., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.023 · Cited by 367 · see citing works
Towards targeting the breast cancer immune microenvironment
Harris, M., Savas, P., Virassamy, B., O’Malley, M. M. R., Kay, J., Mueller, S. N., Mackay, L., Salgado, R., & Loi, S. (2024) · Nature Reviews. Cancer · doi:10.1038/s41568-024-00714-6 · Cited by 376 · see citing works
Spatial predictors of immunotherapy response in triple-negative breast cancer
Wang, X. Q., Danenberg, E., Huang, C., Egle, D., Callari, M., Bermejo, B., Dugo, M., Zamagni, C., Thill, M., Anton, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06498-3 · Cited by 369 · see citing works
Atlas of clinically distinct cell states and ecosystems across human solid tumors
Luca, B. A., Steen, C. B., Matusiak, M., Azizi, A., Varma, S., Zhu, C., Przybył, J., Espín-Pérez, A., Diehn, M., Alizadeh, A. A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.014 · Cited by 344 · see citing works
Spatial components of molecular tissue biology
Palla, G., Fischer, D. S., Regev, A., & Theis, F. J. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01182-1 · Cited by 315 · see citing works
Evaluation of Deep Learning Strategies for Nucleus Segmentation in Fluorescence Images
Caicedo, J. C., Roth, J., Goodman, A., Becker, T., Karhohs, K. W., Broisin, M., Molnár, C., McQuin, C., Singh, S., Theis, F. J., et al. (2019) · Cytometry Part A · doi:10.1002/cyto.a.23863 · Cited by 327 · see citing works
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche
Baldominos, P., Barbera-Mourelle, A., Barreiro, O., Huang, Y., Wight, A. E., Cho, J.-W., Zhao, X., Estivill, G., Adam, I., Sanchez, X., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.033 · Cited by 315 · see citing works
Single-cell metabolic profiling of human cytotoxic T cells
Hartmann, F. J., Mrdjen, D., McCaffrey, E., Glass, D. R., Greenwald, N. F., Bharadwaj, A., Khair, Z., Verberk, S. G. S., Baranski, A., Baskar, R., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0651-8 · Cited by 310 · see citing works
The immunoregulatory landscape of human tuberculosis granulomas
McCaffrey, E., Donato, M., Keren, L., Chen, Z., Delmastro, A. C., Fitzpatrick, M. B., Gupta, S., Greenwald, N. F., Baranski, A., Graf, W., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01121-x · Cited by 309 · see citing works
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
Ali, H. R., Jackson, H. W., Zanotelli, V. R., Danenberg, E., Fischer, J. R., Bardwell, H. A., Provenzano, E., CRUK IMAXT Grand Challenge Team, Ali, H. R., Sa’d, M. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0026-6 · Cited by 304 · see citing works
Metabolic adaptation of lymphocytes in immunity and disease
Chapman, N. M., & Chi, H.-B. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.012 · Cited by 263 · see citing works
Taylor, M. J., Lukowski, J. K., & Anderton, C. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00439 · Cited by 300 · see citing works
An end-to-end workflow for multiplexed image processing and analysis
Windhager, J., Zanotelli, V. R., Schulz, D., Meyer, L., Daniel, M., Bodenmiller, B., & Eling, N. (2023) · Nature Protocols · doi:10.1038/s41596-023-00881-0 · Cited by 290 · see citing works
Genetic and non-genetic clonal diversity in cancer evolution
Black, J. R., & McGranahan, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00336-2 · Cited by 287 · see citing works
Taube, J. M., Aktürk, G., Angelo, M., Engle, E. L., Gnjatic, S., Greenbaum, S., Greenwald, N. F., Hedvat, C. V., Hollmann, T. J., Juco, J. W., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000155 · Cited by 289 · see citing works
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma
AbdulJabbar, K., Raza, S. E. A., Rosenthal, R., Jamal‐Hanjani, M., Veeriah, S., Akarca, A. U., Lund, T., Moore, D. A., Salgado, R., Bakir, M. A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0900-x · Cited by 287 · see citing works
Dissecting cellular crosstalk by sequencing physically interacting cells
Giladi, A., Cohen, M., Medaglia, C., Baran, Y., Li, B., Zada, M., Bost, P., Blecher‐Gonen, R., Salame, T., Mayer, J. U., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0442-2 · Cited by 269 · see citing works
Breast tumor microenvironment structures are associated with genomic features and clinical outcome
Danenberg, E., Bardwell, H. A., Zanotelli, V. R., Provenzano, E., Chin, S., Rueda, O. M., Green, A. R., Rakha, E. A., Aparicio, S. A. J. R., Ellis, I. O., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01041-y · Cited by 273 · see citing works
GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
Kumar, A., Khani, A. T., Ortiz, A. S., & Swaminathan, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901277 · Cited by 277 · see citing works
Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.003 · Cited by 280 · see citing works
Bairi, K. E., Haynes, H. R., Blackley, E. F., Fineberg, S., Shear, J., Turner, S., de Freitas, J. R., Sur, D. G., Amendola, L. C., Gharib, M., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00346-1 · Cited by 271 · see citing works
Hammerl, D., Martens, J. W. M., Timmermans, M., Smid, M., Trapman-Jansen, A. M., Foekens, R., Isaeva, O. I., Voorwerk, L., Balcioglu, H. E., Wijers, R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25962-0 · Cited by 262 · see citing works
Host tissue determinants of tumour immunity
Salmon, H., Remark, R., Gnjatic, S., & Mérad, M. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0125-9 · Cited by 258 · see citing works
Big data in basic and translational cancer research
Jiang, P., Sinha, S., Aldape, K., Hannenhalli, S., Sahinalp, C., & Ruppin, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00502-0 · Cited by 254 · see citing works
MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging
Schapiro, D., Sokolov, A., Yapp, C., Chen, Y., Muhlich, J. L., Hess, J. M., Creason, A., Nirmal, A. J., Baker, G. J., Nariya, M. K., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01308-y · Cited by 229 · see citing works
An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity
Glass, D. R., Tsai, A. G., Oliveria, J. P., Hartmann, F. J., Kimmey, S. C., Calderon, A. A., Borges, L., Glass, M. C., Wagar, L. E., Davis, M. M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.013 · Cited by 232 · see citing works
Stoltzfus, C. R., Filipek, J., Gern, B. H., Olin, B. E., Leal, J. M., Wu, Y., Lyons‐Cohen, M. R., Huang, J. Y., Paz-Stoltzfus, C. L., Plumlee, C. R., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107523 · Cited by 241 · see citing works
Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer
Mehta, A., Kadel, S., Townsend, M. G., Oliwa, M., & Guerriero, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643771 · Cited by 206 · see citing works
Intratumoral Heterogeneity: More Than Just Mutations
Hinohara, K., & Polyák, K. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.03.003 · Cited by 231 · see citing works
Tietscher, S., Wagner, J., Anzeneder, T., Langwieder, C., Rees, M., Sobottka, B., de Souza, N., & Bodenmiller, B. (2023) · Nature Communications · doi:10.1038/s41467-022-35238-w · Cited by 224 · see citing works
Miller, B. F., Huang, F., Atta, L., Sahoo, A., & Fan, J. (2022) · Nature Communications · doi:10.1038/s41467-022-30033-z · Cited by 208 · see citing works
Karacosta, L. G., Anchang, B., Ignatiadis, N., Kimmey, S. C., Benson, J. A., Shrager, J. B., Tibshirani, R. J., Bendall, S. C., & Plevritis, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-13441-6 · Cited by 211 · see citing works
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
Phillips, D. J., Matusiak, M., Rivero‐Gutiérrez, B., Bhate, S. S., Barlow, G. L., Jiang, S., Demeter, J., Smythe, K. S., Pierce, R. H., Fling, S. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26974-6 · Cited by 223 · see citing works
Kuett, L., Catena, R., Özcan, A., Plüss, A., Ali, H. R., Sa’d, M. A., Alon, S., Aparicio, S. A. J. R., Battistoni, G., Balasubramanian, S., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00301-w · Cited by 219 · see citing works
The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution
Nirmal, A. J., Maliga, Z., Vallius, T., Quattrochi, B., Chen, A. A., Jacobson, C. A., Pelletier, R. J., Yapp, C., Arias-Camison, R., Chen, Y., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1357 · Cited by 209 · see citing works
Innate Immunity and Cancer Pathophysiology
Maiorino, L., Daßler‐Plenker, J., Sun, L., & Egeblad, M. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-032221-115501 · Cited by 219 · see citing works
Asleh, K., Riaz, N., & Nielsen, T. O. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02476-1 · Cited by 221 · see citing works
CellCharter reveals spatial cell niches associated with tissue remodeling and cell plasticity
Varrone, M., Tavernari, D., Santamaria‐Martínez, A., Walsh, L. A., & Ciriello, G. (2023) · Nature Genetics · doi:10.1038/s41588-023-01588-4 · Cited by 210 · see citing works
Tumour heterogeneity and the evolutionary trade-offs of cancer
Hausser, J., & Alon, U. S. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0241-6 · Cited by 209 · see citing works
Glial and myeloid heterogeneity in the brain tumour microenvironment
Andersen, B. M., Akl, C. F., Wheeler, M. A., Chiocca, E. A., Reardon, D. A., & Quintana, F. J. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00397-3 · Cited by 211 · see citing works
Chen, Y., Jia, K., Sun, Y. L., Zhang, C., Li, Y., Zhang, L., Chen, Z., Zhang, J., Hu, Y., Yuan, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32570-z · Cited by 210 · see citing works
If we build it they will come: targeting the immune response to breast cancer
Gatti-Mays, M. E., Balko, J. M., Gameiro, S. R., Bear, H. D., Prabhakaran, S., Fukui, J. A., Disis, M. L., Nanda, R., Gulley, J. L., Kalinsky, K. M., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0133-7 · Cited by 207 · see citing works
Spatial biology of cancer evolution
Seferbekova, Z., Lomakin, A., Yates, L. R., & Gerstung, M. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00553-x · Cited by 210 · see citing works
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
Thomas, R., Al‐Khadairi, G., & Decock, J. V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.600573 · Cited by 205 · see citing works
Spatial multi-omics analyses of the tumor immune microenvironment
Hsieh, W.-C., Budiarto, B. R., Wang, Y., Lin, C., Gwo, M.-C., So, D. K., Tzeng, Y.-S., & Chen, S.-Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00879-y · Cited by 217 · see citing works
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Berry, S., Giraldo, N. A., Green, B., Cottrell, T. R., Stein, J. E., Engle, E. L., Xu, H., Ogurtsova, A., Roberts, C. A., Wang, D., et al. (2021) · Science · doi:10.1126/science.aba2609 · Cited by 195 · see citing works
Immune monitoring using mass cytometry and related high-dimensional imaging approaches
Hartmann, F. J., & Bendall, S. C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0338-z · Cited by 203 · see citing works
SM-Omics is an automated platform for high-throughput spatial multi-omics
Vicković, S., Lötstedt, B., Klughammer, J., Mages, S., Segerstolpe, Å., Rozenblatt–Rosen, O., & Regev, A. (2022) · Nature Communications · doi:10.1038/s41467-022-28445-y · Cited by 194 · see citing works
Integration of whole transcriptome spatial profiling with protein markers
Ben‐Chetrit, N., Niu, X., Swett, A. D., Sotelo, J., Jiao, M. S., Stewart, C. M., Potenski, C. J., Mielinis, P., Roelli, P., Stoeckius, M., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01536-3 · Cited by 212 · see citing works
Fountzilas, E., Pearce, T. E., Baysal, M. A., Chakraborty, A., & Tsimberidou, A. M. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01471-y · Cited by 219 · see citing works
High-resolution alignment of single-cell and spatial transcriptomes with CytoSPACE
Vahid, M. R., Brown, E. L., Steen, C. B., Zhang, W., Jeon, H. S., Kang, M., Gentles, A. J., & Newman, A. M. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01697-9 · Cited by 190 · see citing works
TGF-β suppresses type 2 immunity to cancer
Liu, M., Kuo, F., Capistrano, K. J., Kang, D., Nixon, B. G., Shi, W., Chou, C., Do, M. H., Stamatiades, E. G., Gao, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2836-1 · Cited by 189 · see citing works
A spatially resolved timeline of the human maternal–fetal interface
Greenbaum, S., Averbukh, I., Soon, E., Rizzuto, G. A., Baranski, A., Greenwald, N. F., Kagel, A., Bosse, M. M., Greenwood, E. A., Khair, Z., et al. (2023) · Nature · doi:10.1038/s41586-023-06298-9 · Cited by 189 · see citing works
Wu, J., Gao, F., Wang, C., Qin, M., Han, F., Xu, T., Hu, Z., Long, Y., He, X., Deng, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1310-0 · Cited by 188 · see citing works
High-dimensional cell-level analysis of tissues with Ce3D multiplex volume imaging
Li, W., Germain, R. N., & Gerner, M. Y. (2019) · Nature Protocols · doi:10.1038/s41596-019-0156-4 · Cited by 186 · see citing works
Akhoundova, D., & Rubin, M. A. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.011 · Cited by 188 · see citing works
Decoding the tumor microenvironment with spatial technologies
Walsh, L. A., & Quail, D. F. (2023) · Nature Immunology · doi:10.1038/s41590-023-01678-9 · Cited by 191 · see citing works
Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully
Lin, B., Du, L., Li, H., Zhu, X. M., Cui, L., & Li, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110873 · Cited by 185 · see citing works
Chen, J. H., Nieman, L. T., Spurrell, M., Jorgji, V., Elmelech, L., Richieri, P. M., Xu, K. H., Madhu, R., Parikh, M., Zamora, I., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01792-2 · Cited by 184 · see citing works
Mass spectrometry imaging for spatially resolved multi-omics molecular mapping
Zhang, H., Lu, K. H., Ebbini, M., Huang, P., Lu, H., & Li, L. (2024) · npj Imaging · doi:10.1038/s44303-024-00025-3 · Cited by 180 · see citing works
Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies
Baharlou, H., Canete, N. P., Cunningham, A. L., Harman, A. N., & Patrick, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02657 · Cited by 176 · see citing works
- Authors
- Keren, L., Bosse, M., Marquez, D., Angoshtari, R., Jain, S., Varma, S., Yang, S.-R., Kurian, A., Van Valen, D., West, R., Bendall, S. C., & Angelo, M.
- Affiliations
- Stanford University (US)
- Stanford Medicine (US)
- Corresponding author
- Bendall, Sean C.
- Angelo, Michael
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 174
- Issue
- 6
- Pages
- 1373-1387.e19
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6132072
- OpenAlex
- W2890156321
- Cited by
- 1,183
- References
- 54
- Citations by year
- 2026: 222 · 2025: 147 · 2024: 141 · 2023: 164 · 2022: 153 · 2021: 167 · 2020: 105 · 2019: 74 · 2018: 9
- FWCI
- 33.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- Damon Runyon Cancer Research Foundation (DRG-2292-17, DRG-2017-09)
- EMBO Long-Term fellowship (ALTF 1128-2016)
- NIH F32 Postdoctoral Fellowship
- Burroughs Wellcome PDEP award
- The Allen Discovery Center at Stanford University
- Crowdflower A.I.
- NIH (5R01CA18390402, 1DP2OD022550-01, 1-R00-GM104148-01, 5U19AI116484-02, U19 AI104209, 1-DP5-OD019822, 1R01AG056287-01, 1R01AG057915-01, 1U24CA224309-01)
- Bill and Melinda Gates Foundation
- Stanford Cancer Institute (NSF ECCS-1542152)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- triple-negative breast cancer, tumor immune microenvironment, MIBI, immune checkpoint molecules, PD-1, PD-L1, IDO, immune cell infiltration, patient survival
- MeSH terms
- Machine Learning, Lymphocyte Activation Gene 3 Protein, Female, Humans, Lymphocytes, Mass Spectrometry, Antigens, CD, Cluster Analysis, Principal Component Analysis, Indoleamine-Pyrrole 2,3,-Dioxygenase, Kaplan-Meier Estimate, Tumor Microenvironment, B7-H1 Antigen, Programmed Cell Death 1 Receptor, Spatial Analysis, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
